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Abstract
Thyroid calcification is frequent in thyroid nodules. The aim of our study was to evaluate the
prevalence of calcifications in thyroid tissue samples of patients with various thyroid dis-
eases, and to identify their composition according to their localization. Among 50 thyroid
samples included, 56% were malignant (papillary carcinoma) and 44% were benign (ade-
noma, multinodular goiter, Graves’ disease, sarcoidosis). Calcifications were found in 95%
of samples using polarised light microscopy, whereas only 12% were described in initial
pathological reports. Three types were individualised and analyzed by infrared spectrometry
(μFTIR): colloid calcifications composed of calcium oxalate, capsular calcifications and
psammoma bodies, both composed of calcium phosphate. Of notice, psammoma bodies
characterized by FE-SEM were composed of concentric structure suggesting a slow pro-
cess for crystal deposition. Calcium phosphates were found only in malignant samples
whereas calcium oxalate was not associated with a define pathology. Proliferation assessed
by KI67 staining was high (33% of positive follicles), and RUNX2, OPN, and CD44 positive
staining were detected in thyrocytes with a broad variation between samples. However, thyr-
ocyte proliferation and differentiation markers were not associated with the number of crys-
tals. TRPV5 and CaSR expression was also detected in thyrocytes. mRNA transcripts
expression was confirmed in a subgroup of 10 patients, altogether with other calcium trans-
porters such as PMCA1 or Cav1.3. Interestingly, TRPV5 mRNA expression was signifi-
cantly associated with number of colloid calcifications (rho = -0.72; p = 0.02). The high
prevalence of calcium oxalate crystals within colloid gel raises intriguing issues upon follicle
physiology for calcium and oxalate transport.
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Introduction
Calcifications are frequently detected in thyroid tissue by pathologists. However, crystal com-
position and/or pathophysiological processes have been poorly investigated as no clinical rele-
vance was reported either for diagnosis or prognosis.
Thyroid nodules are very common in the population and about 5% of them are malignant
[1] with a prevalence of calcification in around 40% of malignant nodules and 20% of benign
nodules [2]. Thyroid ultrasound of micro and macrocalcifications are indeed well described in
the literature. TIRADS scoring (Thyroid Image Reporting And Data System) is frequently
used in clinical practice as risk factor for thyroid lesions [3]: microcalcifications are predictive
of malignancy [2,4] whereas central macrocalcifications are usually predictive of benign
pathology. However, several diseases may be associated with calcifications such as thyroid pap-
illary carcinoma, nodular goiters or Graves’ disease, and despite several studies, no clear asso-
ciation between calcifications and pathology was demonstrated [5–10], (conversely to
microcalcifications in cervical lymph nodes which are predictive of thyroid papillary carci-
noma metastasis [11]). One caveat is due to the fact that papillary carcinoma (and particularly
microcarcinoma) is frequently incidental, associated with other pathologies such as Grave’s
disease or nodular goiters [12].
At the microscopic scale, three types of thyroid calcifications are described [13]: 1) Psam-
moma bodies presenting as round and lamellar calcification which do not polarize; 2) Capsular
calcification usually described as unspecific eggshell calcifications of various sizes, surrounding
the capsule; 3) Colloid calcifications within colloid of follicles, presenting as birefringent crys-
tals under polarized light microscopy [5]. Crystals within follicle colloid were reported only in
human thyroids [6,14] and identified as calcium oxalate [6], whereas hydroxyapatite was
found in almost all macroscopic calcifications from thyroid tissue extracts [7].
Our focus, here, was to study the prevalence of calcifications in thyroid tissue sample of
patients with various thyroid diseases, and to identify their composition according to their
localization.
Materials and methods
Samples
Materials and participants. All formalin-fixed paraffin-embedded (FFPE) samples from
partial or total surgical thyroidectomy collected during six months (between July and Decem-
ber 2014) were included in the study. Ten frozen thyroid samples collected during the year
2016 were also included for mRNA study.
Fifty patients were included and six patients were operated twice during the 6 months for
completion thyroidectomy. Partial thyroidectomy (n = 28) and total thyroidectomy (n = 28)
were included (Fig 1).
Ethical consideration. The study was approved by the Commission d’Evaluation et de
Recherche Observationnelle en OtoRhinoLaryngologie (CEROL) (Ethics Committee of the
Society of Otolaryngology, France). In accordance with French legislation (Public Health Code
amended by law No. 2004–806, August 9, 2004 and the Huriet-Se´rusclat Law 88–1138, Decem-
ber 20, 1988), a patient information letter was issued and verbal informed consent was
obtained. Data were strictly anonymous.
Sample preparation. Slices were prepared from FFPE blocks. For each patient, focal
lesion such as adenoma, papillary carcinoma (with follicular or papillary architecture) or
microcarcinomas were analyzed. Blocks from diffuse lesion encountered in multinodular goi-
ter, Graves’ disease, or sarcoidosis were randomly selected and analyzed. FFPE blocks were
Thyroid microcalcifications
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sectioned with a microtome (Microtom HM 325, ThermoFisher Scientific, Waltham, Massa-
chusetts, United States) to obtain 4μm thick sections. Three consecutive sections were realized
for each block and stained for Von Kossa stain (Von Kossa, to identify and localize calcium
deposits in paraffin sections), and Hematoxylin and Eosin stain (HE) and one section was ana-
lyzed using FE-SEM (Zeiss Supra 55VP Field Emission Scanning Electron Microscope) and
micro Fourier transform infrared spectrometry (μFTIR) (Spotlight 400 infrared imager, Per-
kin-Elmer, Villebon-sur-Yvette, France). Others sections were stained on SuperFrost1 for
immunohistochemistry.
Identification and characterization of calcium deposits
Morphological study. Calcium deposits were examined by normal and polarized light
microscopy to determine their size, shape, occurrence, distribution and location, on HE and
on Von Kossa slices. Calcifications were counted on the HE slice with polarized light, on five
random fields (x100 magnification).
Composition of calcifications was performed by μFTIR. Data were collected in the reflec-
tion mode between 4000 and 700cm-1, with a resolution of 4 cm-1 [15]. Microcalcifications
were further characterized by FE-SEM (Zeiss Supra 55VP Field Emission Scanning Electron
Microscope) in order to describe their morphology at the micrometer scale with a 3D recon-
struction [16]. Energy dispersive x-ray analysis (EDX) was used for some samples for the ele-
mental analysis [17].
Fig 1. Patients characteristics according to thyroid disease.
https://doi.org/10.1371/journal.pone.0224138.g001
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Immunohistochemistry and RT-PCR. After paraffin removal, antigen-retrieval, and
incubation with a peroxydase blocking solution and bovine serum albumin (BSA) to reduce
background staining, sections were incubated with one of the following primary antibodies
overnight at 4˚C: anti-TTF1 (Dako,Glostrup, Denmark), KI67, osteopontin, RUNX2, TRPV5,
calcitonin (Abcam, Paris, France), anti-CD44 (Exbio, Prague, Czech Republic) and anti-CaSR
(Fisher, Illkirch, France). Sections were revealed by a Biotin-Free Polyvalent AEC secondary
antibody (3-amino-9-ethylcarbazole, Dako; Glostrup, Denmark). Counterstaining was per-
formed with HE. Negative controls were performed by omitting the primary antibody.
Proliferation index was performed for each slice on ten random fields with x400 magnifica-
tion and defined as the ratio of the number of vesicles with at least more than 10% of KI67 pos-
itive thyrocytes/total number of vesicles.
Snap frozen samples from ten patients collected in the operating room were used for
RT-PCR and HE staining. A normal frozen human kidney sample was used as control. Total
RNA purification was performed using Trizol-chloroform protocol according to the manufac-
ter’s instructions. cDNA were synthesized from 1μg of total RNA in 20μL with a reverse tran-
scriptase (ThermoFisher Scientific, Waltham, Massachusetts, United States). Amplification
was done with SYBR Green (SensiFast SYBR, Bioline, London, United Kingdom) and
sequence specific primers by thermocycler (Light Cycler 480, Roche, Bale, Switzerland). The
following protocol was used: 95˚C for 5 minutes then 45 cycles at 95˚C for 15 seconds, 60˚C
for 15 seconds and 72˚C for 15 seconds. All samples were normalized to housekeeping gene
expression human 18S rRNA. The primers sequences are detailed in Table 1.
Statistical analysis. Results are expressed by median and interquartile range. Comparison
between different groups were performed using a nonparametric Wilcoxon-Mann-Whitney
test for quantitative variables and a Chi2 test for qualitative variables (BiostaTGV software). A
non parametric Spearman test was used for correlations. Significance was defined as p<0.05.
Results. Among our population, 38 patients were female and 12 were males with a median
age of 49 [40–54] years. As shown in Fig 1, papillary carcinoma was diagnosed in 28 thyroids.
28% (n = 8/28) were microcarcinoma and 58% (n = 16/28) were multiple foci (from two to
twelve foci). This population was thus referred as a “Tumor group” and compared to a “non
Tumor group” of 22 patients including 5 adenomas, 11 multinodular goiters, 5 Graves’ dis-
eases and one sarcoidosis. Of notice, in the Tumor group, papillary, papillo-follicular and
papillo-oncocytic architecture were encountered in 16, 9 and 3 cases respectively. Moreover,
aside the detection of carcinoma, a multinodular goiter was present in 6 patients, one patient
had Graves’ disease and three had an associated vesicular adenoma.
Morphologic study
Thyroid calcifications identification and localization. Among 56 analyzed samples, the
presence of crystal deposits detected by the pathologist was reported only in 7 cases: psam-
moma were detected in 3 cases and colloid calcified nodules in 4 cases. After careful proofread-
ing by our pathologist on FFPE slices without polarized microscopy, psammoma bodies were
confirmed in 3 samples (5%), calcifications outlying the nodules were found in 5 samples
(9%). Of notice, colloid calcifications were detected in 4 samples, however under polarized
light microscopy, they were found in 51 out of 56 samples (i.e. 91%). Overall 95% of the sam-
ples had at least one of the three types of calcification described above.
As shown in Fig 2A, 2B, 2C and 2D, colloid calcifications may be detected by Von Kossa
staining or by polarized light microscopy and not by hematoxylin eosin staining. These calcifi-
cations are located in the follicles and are birefringent under polarized light. At least one col-
loid calcification per slice was detected in 91% of cases. However, calcifications number may
Thyroid microcalcifications
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vary considerably between the different samples with a mean number of 50 (+/-97) and a
median number of 11 [2–44]. Colloid crystal size was also variable with a median diameter of
16 μm (from 1 to 374μm).
As shown in Fig 2E, 2F, 2G and 2H, psammoma bodies were detected by Von Kossa or HE
staining in the interstitium outside follicles’ colloid, as round, lamellar and concentric calcifi-
cations with no polarization property. Median diameter was 100 μm [75–116].
Last, calcifications outlying nodules in the capsules were very large, easily detected by
hematoxylin and eosin staining, with no polarization (Fig 2I, 2J and 2K).
Composition of thyroid crystals. A subgroup of 27 patients was studied using a μFTIR
spectrometry imager: 18 patients in the tumor group and 9 patients in the non tumor group.
Overall, 132 calcifications were analyzed and classified according to their tissue localization:
colloid, interstitial or capsular calcifications (Table 2). All colloid calcifications (100%, n =
104) were composed of calcium oxalate with calcium oxalate monohydrate (COM) in 58% of
cases, calcium oxalate dihydrate (COD) in 14% and a mixture in 28% of cases (COM + COD).
No calcium phosphate was detected even in small amount. Conversely, all psammoma bodies
(100%, n = 24) were composed of calcium phosphate, the most frequent component was car-
bonated calcium apatite (CA) (88% of cases) either alone (30%) or mixed with a mixture of
amorphous carbonated calcium phosphate (ACCP) and CA (58%). As shown Table 2, other
calcium phosphates such as whitlockite could also be detected. Of notice, capsule calcifications
were also calcium phosphates in all samples (100%, n = 5), with also the presence of CA,
ACCP and whitlockite compounds.
Table 1. Primer sequences for mRNA transcripts.
Human TRPM6 Sense strand hTRPM6-3var-s AAGGACTCCAGGTGCCAAT
Antisense strand hTRPM6-3var-as GCTGTACTCCTCTTCAGAGATGC
Human VDR Sense strand hVDR-3var-s GACCTGTGGCAACCAAGACT
Antisense strand hVDR-3var-as GAACTTGATGAGGGGCTCAA
Human NCX1 Sense strand hSLC8A1-4var-s GCCCTTGTGGTTGGGACT
Antisense strand hSLC8A1-4var-as CCACATTCATCGTCGTCATC
Human PMCA1 Sense strand hATP2B1-2var-s TCCAGAAGGGGATAATGCAC
Antisense strand hATP2B1-2var-as TCAATCCAACCAGTTTCACCT
Human Calgranulin B Sense strand hS100A9s GTGCGAAAAGATCTGCAAAA
Antisense strand hS100A9as TCAGCTGCTTGTCTGCATTT
Human TRPV5 Sense strand hTRPV5s AGATCGACTCCTGGGGAGA
Antisense strand hTRPV5as TGGGGTCTGTTCCAGAATTT
Human TRPV6 Sense strand hTRPV6s AGAGCCGAGATGAGCAGAAC
Antisense strand hTRPV6as GAAGGAGAGGAGACTCCCAGA
Human MGLA Sense strand hMGP2vars TCACATGAAAGCATGGAATCTTA
Antisense strand hMGP2varas ACAGGCTTAGAGCGTTCTCG
Human Cav1.3 Sense strand hcav1.3_3vars TTTGGTTCGAACGGCTCTTA
Antisense strand hcav1.3_3varas AGCCCGAAGTTCTTCATTAGC
Human CaV1.3 var 1 Sense strand hCASRvar1s CGAGGAGAAAATCCTGTGGA
Antisense strand hCASRvar1as AGTTGGAGAAGGGCACCTG
Human CaV1.3 var 2 Sense strand hCASRvar2s CTTTCGCGCAGGAGAGTG
Antisense strand hCASRvar2as GCCTCCTGTGATGCCTTTC
Human Oste´opontin Sense strand hSPP1s AGGACTCCATTGACTCGAACGA
Antisense strand hSPP1as CACCTCGGCCATCATATGTGT
Human Calcitonin Sense strand hCALCAs CACGCTCAGTGAGGACGAAG
Antisense strand hCALCAas AAGTCCTGCGTGTATGTGCC
https://doi.org/10.1371/journal.pone.0224138.t001
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Morphology of thyroid crystals. In order to detect at the micrometer scale crystal mor-
phology according to chemical composition, we processed and analyzed both on FE-SEM
and μFTIR spectrometry forty-five different samples containing crystallites. Fig 3 illustrates
Fig 2. Illustration of the different patterns of crystals deposits in thyroid tissue using optic microscopy. Crystals located were misdiagnosed by Hematoxylin and
Eosin staining (HE) (arrows show the location of colloid crystals that are misdiagnosed by HE staining in (a), but detected by Von Kossa staining as dark composits
(arrows show the black staining of crystals with VK coloration inside the vesicles in (b) and also by polarized light microscopy (arrows show the birefringent character of
colloid crystals in (c) and (d), magnification x40). Psammoma bodies were detected both by HE (arrows show the HE staining of psammoma bodies outside the vesicles in
(e), and Von Kossa staining (arrows show the black staining of psammoma bodies with VK coloration in (f) with no polarized property and (g) psammoma bodies shown
with arrows do not have birefringent character). A lamellar aspect was detected on silver coated slide without staining (the arrow show a psammoma body in (h)) (x200
magnification). Large calcification in nodule’s capsule were easily detected with HE (in (i) and (j) capsule calcification are shown with arrows) and also on silver coated
slide without staining (an arrow shows in (k) the same capsule calcification than (j) in a silver coated slide without staining) (x40 magnification).
https://doi.org/10.1371/journal.pone.0224138.g002
Table 2. Composition of crystal deposits in thyroid samples according to their location.
n
(= 132)
Calcium oxalate Calcium Phosphate
COM COD COM+
COD
CA ACCP CA + ACCP Other
Colloid calcifications 104 58% 14% 28% 0 0 0 0
Psammoma bodies 24 0 0 0 30% 8% 58% 4%�
Capsule calcifications 4 0 0 0 25% 0 50% 25%�
COM = calcium oxalate monohydrate. COD = calcium oxalate dihydrate. CA = carbonated calcium apatite. ACCP = amorphous carbonated calcium phosphate.
�One psammoma body was composed of CA with Whitlockite.
��One capsule calcification was a mixture of CA, ACCP and Whitlockite.
https://doi.org/10.1371/journal.pone.0224138.t002
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representative results. Psammoma bodies appeared as concentric and lamellar structures (Fig
3A, 3B and 3C) with peripheral striations suggesting growth lines. Calcium phosphate com-
pounds did not exhibit the usual spherical morphology described in kidney or prostate gland
[18,19].
Conversely, aggregated small spheres of different size (at micrometer scale) were detected
in capsular calcifications (Fig 3E, 3F and 3G) with an internal radial structure (Fig 3G).
As shown in Fig 3, colloid calcifications composed of pure COM (Fig 3I, 3J and 3K) or pure
COD (Fig 3M, 3N and 3O) had an overlap sticks appearance whereas COD is usually described
as bipyramidal structure in urine. The presence of calcium was further confirmed using elec-
tron diffraction X-ray microscope (EDX, S1 Fig), thus ruling out other cations associated with
oxalate crystallites.
Pathophysiological processes
Colloid calcification and thyrocytes’ phenotypes. We next focused on colloid calcifica-
tions in order to better understand the pathophysiological process leading to the onset of
COM and COD crystals in most biopsies. Indeed, thyroid vesicles are a confined space con-
taining colloid material, surrounded by thyrocytes and a basement membrane. In all tested
samples, TTF1 was expressed on thyrocytes; however, proliferation was unexpectedly high,
with a positive KI67 staining in 33% of vesicles [6%-54%], (minimum and maximum
Fig 3. Illustration of the different patterns of crystals deposits in thyroid tissue using FE-SEM according to composition assessed by μFTIR spectrometry. (a) (b) (c)
Psammoma bodies with presence of growth lines in FE-SEM (a) arrow shows the psammoma body in FE-SEM, (b) and (c) arrows indicate the growth lines on the same
psammoma body shown in (a), with a higher magnification), (d) FTIR absorption spectrum showing a mixture of CA and ACCP. (e) (f) (g) Capsule calcifications detected
as an agglomeration of small spherules by FE-SEM (arrows show the same capsule calcification with different magnifications). (h) FTIR absorption spectrum showing a
mixture of CA and ACCP. (i) (j) (k) COM, assessed by FTIR absorption (arrows show the same COM crystal on the three images with different magnifications). (l)
appearing as overlapped sticks by FE-SEM. (m) (n) (o) COD with a pattern looking close to COM structure with overlapped sticks and sometimes perpendicular intersects
(arrows show the COD crystals with different magnifications). (p) FTIR absorption spectrum of COD crystal.
https://doi.org/10.1371/journal.pone.0224138.g003
Thyroid microcalcifications
PLOS ONE | https://doi.org/10.1371/journal.pone.0224138 October 24, 2019 7 / 13
respectively: 0% and 89%) (Fig 4). Moreover, as shown in Fig 4, positive RUNX2, OPN, and CD44
staining were also detected in thyrocytes with a broad variation between samples and no obvious
significant staining intensity between the tumor and non tumor group (S3 Table). Of notice, no
link was found for all the biomarkers mentioned above and colloid calcification number.
Thyrocyte expression of calcium transporters. Calcium transporters expression was
studied by RT-PCR in a subgroup of ten frozen thyroid samples. As shown in Table 3, several
calcium transporters expressed in the kidney tissue were also expressed at variable but
Fig 4. Immunochemistry of Ki67, RUNX2, OPN, CD44, TRPV5 and CaSR in thyroid sample. Representative illustration of Ki67 (a) (arrows
indicating Ki67 positive cells), RUNX2 (b) (arrows indicating RUNX2 positive cells), OPN (c) (arrows indicating OPN positive cells) and CD44
staining (d) (arrows indicating CD44 staining) in thyroid samples. TRPV5 and CaSR staining in thyroid sample (e) and (g) respectively (arrows
indicating the TRPV5 and CaSR positive cells respectively) compared to a normal kidney sample (f) and (h) respectively. Magnification x100
and x400.
https://doi.org/10.1371/journal.pone.0224138.g004
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significant levels in the thyroid samples such as TRPV5, PMCA1 or Cav1.3, but also the cal-
cium sensor CaSR, and the calcitriol receptor VDR (Table 3). The small number of samples
with only 3 samples in the tumor group, may explain the lack of significant difference found
between the two groups (S2 Table).
However, as shown in Table 3, TRPV5 mRNA was strongly negatively correlated to colloid
calcification number (Rho = -0.72, p = 0.02). Interestingly, TRPV5 mRNA was also positively
associated with Cav1.3 and CaSR transcripts (p = 0.002 and p = 0.01 respectively). TRPV5 pro-
tein expression was confirmed by immunochemistry (Fig 4), with a strong cytoplasmic stain-
ing and in some thyrocytes an apical membrane staining (i.e. facing the colloid). Of notice, as
shown in Fig 4G, a strong nuclear CaSR staining was detected on thyrocytes, whereas this
receptor is localized in cell membranes in the kidney tubules (in the ascending limb of the loop
of Henle) (Fig 4H).
Calcification and cancer. In our small series, there was no statistical correlation between
different type of calcifications confirmed by FTIR and the tumor status. All samples containing
psammoma bodies or capsule calcification, i.e. all calcium phosphates crystals, confirmed
by μFTIR were detected in the tumor group samples, thus giving a 100% specificity. How-
ever,10 samples without calcium phosphate crystals were also classified in the tumor group,
thus giving a poor sensitivity of 44% for this parameter (S1 Table).
Of notice, there was no significant difference for colloid calcification between the group
Tumor and Non Tumor, neither for crystal composition and number, nor the thyrocytes’ phe-
notype (including Ki67, RUNX2, OPN, CD44, TRPV5 or CaSR). Besides, no link was found
between colloid calcification number and patient’s age.
Discussion
In our study, psammoma bodies and capsule calcifications were rare (5% and 9% of our sam-
pling respectively), identified after careful proofreading, associated with papillary carcinoma
and composed of calcium phosphate in 100% of cases. Conversely, colloid calcifications were
initially underestimated, and were detected under a polarized microscope in 91% of cases and
composed of calcium oxalate in 100% of cases with no phosphate compounds.
Psammoma bodies were reported to be associated with a malignant pathology [13,20,21]
and a poor prognosis [22]. According to the current view, psammoma bodies would be ghosts
Table 3. Correlation between colloid calcifications number and mRNA expression of different transporters,
receptors or macromolecular inhibitors in 10 thyroid samples (Spearman test).
Colloid calcification
Rho P value
TRPV5 -0.721 0.02
TRPM6 -0.382 0.28
CaSR1 -0.455 0.19
VDR -0.321 0.37
Cav1.3 -0.539 0.11
PMCA1 -0.200 0.58
MGLA 0.273 0.45
OPN 0.079 0.84
Calgranuline 0.600 0.07
Association of colloid calcifications number (dependent variable) with mRNA expression of candidate genes
(normalized to 18S rRNA and thus expressed in arbitrary units) were tested using a spearman test.
https://doi.org/10.1371/journal.pone.0224138.t003
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of dead papillae [20,22,23]. However, in our series, the presence of psammoma bodies between
the follicles or in the interlobular septa, which are usually described as the location of vessels
or lymphatics [20] does not support this view. Three species of calcium phosphate: carbonated
calcium apatite (CA), amorphous carbonated calcium phosphate (ACCP) and in one case
small amount of whitlockite were detected, with a concentric and lamellar structure, suggest-
ing growth lines and a slow process for crystal deposition. This new intriguing finding raises
the issue of the mechanism of calcium phosphate deposits which remains unravel.
As 20 out of 56 samples without calcium phosphate crystals were also classified in the
tumor group, malignity cannot be ruled out according to calcium phosphate content within
crystals. Moreover, a previous study by Mathonnet et al [7] found calcium phosphate in nearly
all their samples with only six cancers out of 34 samples. As samples in this latter study were
selected upon the presence of macroscopic calcifications, we assume that most selected tissues
contained capsule calcifications and not psammoma bodies.
Colloid calcifications are frequent and were found in 79% of autopsies [6]. They are
described only in humans and not in animals [6,14] and were reported to contain calcium oxa-
late [5,6,9,24]. Using μFTIR spectrometry, we could further analyze their composition and
found pure COM in 58% of cases and COD or COM + COD in all other cases. Calcium oxalate
supersaturation process within colloid gel leading to a high prevalence of COM remains an
open question. Indeed, oxalate concentration was reported as a major determinant for COM
formation in urine [25]. Oxalate is usually found in mitochondria or in endoplasmic reticulum
and its extracellular presence is intriguing. Iodine transporters (or other halogen elements
such as bromine) in thyrocytes ensuring vectorial transport through colloid gel may potentially
also transport other anions such as oxalate. Alternatively, some specific oxalate membrane
transporters in the thyrocytes may be at play. Intriguingly, COD crystals had very different fea-
tures from what is described in kidney stones: polarization properties conversely to COD in
kidneys and unusual overlap COD sticks (Fig 3O) on FE-SEM analysis. EDX analysis con-
firmed calcium content in several samples thus ruling out binding of oxalate anions by other
hypothetical cations. We speculate that the surrounding proteins (namely colloid proteins)
may explain the discrepancy between thyroid and kidney COD structure. Calcium supersatu-
ration within colloid gel accounting for COD crystals suggests also an unexpected efficient cal-
cium transport into colloid follicles. Our results show the presence of TRPV5 (transient
receptor potential vanilloid 5) in thyrocytes, a previously reported apical transcellular Ca(2+)
transporter, highly selective for calcium, involved in calcium reabsorption in the kidney and in
the intestine [26]. TRPV5 was described in many other tissues: mammary glands [27], parathy-
roid [28], placenta, prostate, salivary and sweat glands [29], but to our knowledge not yet in
thyroid gland. As shown by RT-PCR, the number of colloid calcification was inversely corre-
lated to the expression of the calcium transport TRPV5, thus suggesting that TRPV5 would
prevent crystal deposits. However, the process of calcium transport into colloid follicle is
beyond the scope of the present study and deserves a specific address in order to test among
other issues TRPV5 regulation by CaSR and the vectorial calcium transport by TRPV5, Cav1.3
and PCAM1 among other candidates.
In our series, no correlation was found between colloid calcification number and age or
gender, conversely to other studies [9,13,14,24]. In accordance with literature, no significant
association between colloid calcifications and pathology was shown. Moreover, proliferation
index was not associated with colloid calcification number; however, KI67 staining detects
only ongoing cell division whereas crystals may be aggregated since months or years.
Limitation of the study: our observational cross sectional study does not allow the under-
standing of crystal deposits chronology. Whereas, prevalence, localization and characteriza-
tions of crystals within thyroids can be assessed, the relevance of thyrocyte proliferation
Thyroid microcalcifications
PLOS ONE | https://doi.org/10.1371/journal.pone.0224138 October 24, 2019 10 / 13
(thyrocytes are usually known to have only few divisions in a lifetime) and differentiation can
only be questioned. We speculate that upregulation of RUNX2, a specific osteoblastic tran-
scription factor altogether with osteopontin (a macromolecular inhibitor) and its receptor
CD44 could be key players for crystal prevention/aggregation. Some correlations could not be
addressed due to small samples, such as correlations between expression of TPV5 mRNA
expression or mRNA expression of various transporters, receptors or macromolecular inhibi-
tors between the Tumor group and the non Tumor Group. Further studies deserve to be per-
formed on a larger sample to address this issue.
Our study is the first to indirectly demonstrate a high concentration of calcium and oxalate
within colloid gel altogether with the expression of several calcium transporters and potential
crystal clearance (i.e; osteopontin and CD44), and as such should be considered preliminary to
further studies focusing on follicle physiology for calcium and oxalate.
Our study shows that psammoma bodies are composed of concentric and lamellar structure
of different species of calcium phosphate suggesting a slow process for crystal deposition out-
side colloid follicles. Conversely, colloid calcifications are very frequent and routinely underes-
timated unless a polarized microscopy examination is performed and composed of calcium
oxalate in 100% of cases with no phosphate compounds. The presence of COM and COD crys-
tals within colloid gel raises intriguing issues upon follicle physiology for calcium and oxalate
vectorial transport. These findings pave the way for interesting perspective and suggest that ex
vivo colloid follicles could be an interesting tool for functional studies.
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